Skip to main content

Page of 2 next disabled
and
  1. No Access

    Article

    Neuroendocrine effects of quipazine in man in health state or with neurological disorders

    The endocrinological actions of quipazine, a direct serotonin receptor agonist, were investigated in both normal subjects (NS) and individuals with neurological disorders,i.e., Huntington's disease (HD), myocloni...

    E. A. Parati, P. Zanardi, D. Cocchi, T. Caraceni in Journal of Neural Transmission (1980)

  2. No Access

    Article

    Failure of MIF-I to affect behavioral responses in patients with parkinson's disease under l-dopa therapy

    In eight subjects with Parkinson's disease under an optimal daily dose of l-dopa, acute administration of MIF-I (200 mg i.v.) did not ameliorate either the total disability score or the intellectual test PM 38 wh...

    T. Caraceni, E. A. Parati, F. Girotti, Ivana Celano, Clara Frigerio in Psychopharmacology (1979)

  3. No Access

    Article

    Familial syringomyelia

    The clinical and neurological features of four siblings (2 ♂, 2 ♀) affected by syringomyelia are described. A fifth sister was affected by an acoustic neurinoma. Since neither parent showed signs of syringomye...

    T. Caraceni, P. Giovannini in Archiv für Psychiatrie und Nervenkrankheiten (1977)

  4. No Access

    Article

    The cerebrospinal fluid choline levels in patients with Huntington's chorea

    Lumbar cerebrospinal fluid (CSF) choline (CH) levels were measured in patients with Huntington's chorea (n = 14). This group was found not to differ significantly from normal controls (n = 13). The values for lum...

    Dr. S. Consolo, H. Ladinsky, S. Bianchi in Archiv für Psychiatrie und Nervenkrankheit… (1977)

Page of 2 next disabled